@vajkoczy What about no honorarium for reviewing papers, writing papers and having to transfer copyright, having to pay obscene fees for single articles. How would you call this in a different context than scientific publishing?
@WBrinjikji Difficult to generalize the results with this distribution: seven studies of EmboTrap comprising 687 patients [7,30,33,35,43,53,63], thirty-four studies of Solitaire comprising 5,690 patients, and fourteen studies of Trevo comprising 3427 patients.
@WBrinjikji@paddynicholson Intuition, but also seeing things that everyone else misses. Like Gad deposition or hand disinfection in obstetrics/ surgery. Can't think of a good endovascular example though...
@WBrinjikji Please be careful with quotes like this on Twitter. All the science deniers will love this coming from a scientist. It's not true for large scale population based breakthrough (big five stroke trials with negative IMS III prior).
I'm happy to announce that I'm officially an Advanced Visiting Fellow at @sheffielduni in the group of @oneiseitwopi ! Looking forward to working together on deep learning methods for image analysis and enjoying some fabulous British food 😀!
Taking Toronto 🇨🇦 by storm! Delighted to see that after an international search, @HeidiSchmidtRad has announced the appointment of @PascalMosimann to be our next Neuroradiology Division Head for the Joint Dept of Medical Imaging @UHN@SinaiHealth@WCHospital Exciting times ahead!
@jmascite@UthsaNsurgRes@UTHealthNeuro Interesting case, you saw no other AchorA, right? Still believe that there must be AchorA supply of the superior one even if the course does not match entirely. Dyna CT with I.a. contrast is magic to identify the relation to parenchyma and visualization of microscopic branches.
Latest in #flowdiversion- https://t.co/IvTAMhtQEw -Madjidyar J et. al report their experience with flow-diverter stent (FDS) reconstruction with single-antiplatelet therapy of ruptured cerebral blood blister and dissecting aneurysms.